Incidence, survival, and risk of cardiovascular events in adult inflammatory myopathies in South Korea: a nationwide population-based study

References

• Dalakas MC. Inflammatory muscle diseases. N Engl J Med 2015;372:1734–47.
   Google Scholar
• Meyer A, Lannes B, Goetz J, Echaniz-Laguna A, Lipsker D, Arnaud L, et al. Inflammatory myopathies: a new landscape. Joint Bone Spine 2018;85:23–33.
   PubMedGoogle Scholar
• Schmidt J. Current classification and management of inflammatory myopathies. J Neuromuscul Dis 2018;5:109–29.
   PubMedGoogle Scholar
• Meyer A, Meyer N, Schaeffer M, Gottenberg J-E, Geny B, Sibilia J. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology (Oxford) 2015;54:50–63.
   PubMed Web of Science ®Google Scholar
• Marie I. Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 2012;14:275–85.
   PubMed Web of Science ®Google Scholar
• Schwartz T, Diederichsen LP, Lundberg IE, Sjaastad I, Sanner H. Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies. RMD Open 2016;2:e000291.
   PubMed Web of Science ®Google Scholar
• Gupta R, Wayangankar SA, Targoff IN, Hennebry TA. Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review. Int J Cardiol 2011;148:261–70.
   PubMed Web of Science ®Google Scholar
• Dobloug GC, Svensson J, Lundberg IE, Holmqvist M. Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study. Ann Rheum Dis 2018;77:40–7.
   PubMed Web of Science ®Google Scholar
• Leclair V, Svensson J, Lundberg IE, Holmqvist M. Acute coronary syndrome in idiopathic inflammatory myopathies: a population-based study. J Rheumatol 2019;46:1509–14.
   PubMed Web of Science ®Google Scholar
• Moshtaghi-Svensson J, Lundberg IE, Von Euler M, Arkema EV, Holmqvist M. The risk of ischemic and hemorrhagic stroke in patients with idiopathic inflammatory myopathies: a Swedish population-based cohort study. Arthritis Care Res 2019;71:970–6.
   Web of Science ®Google Scholar
• Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344–7.
   PubMed Web of Science ®Google Scholar
• Kuo C-F, See L-C, Yu K-H, Chou I-J, Chang H-C, Chiou M-J, et al. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study. Br J Dermatol 2011;165:1273–9.
   PubMed Web of Science ®Google Scholar
• Ohta A, Nagai M, Nishina M, Tomimitsu H, Kohsaka H. Prevalence and incidence of polymyositis and dermatomyositis in Japan. Mod Rheumatol 2014;24:477–80.
   PubMed Web of Science ®Google Scholar
• Furst DE, Amato AA, Iorga ŞR, Gajria K, Fernandes AW. Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle Nerve 2012;45:676–83.
   PubMed Web of Science ®Google Scholar
• Svensson J, Arkema EV, Lundberg IE, Holmqvist M. Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study. Rheumatology (Oxford) 2017;56:802–10.
   PubMed Web of Science ®Google Scholar
• Okada S, Weatherhead E, Targoff IN, Wesley R, Miller FW. International Myositis Collaborative Study Group. Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum 2003;48:2285–93.
   PubMed Web of Science ®Google Scholar
• Rider LG, Shamim E, Okada S, Pandey JP, Targoff IN, O’Hanlon TP, et al. Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci. Arthritis Rheum 1999;42:1285–90.
   PubMed Web of Science ®Google Scholar
• Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E, et al. Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis 2012;71:961–5.
   PubMed Web of Science ®Google Scholar
• Bang SY, Lee KH, Cho SK, Lee HS, Lee KW, Bae SC. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthritis Rheum 2010;62:369–77.
   PubMed Web of Science ®Google Scholar
• Airio A, Kautiainen H, Hakala M. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 2006;25:234–9.
   PubMed Web of Science ®Google Scholar
• Torres C, Belmonte R, Carmona L, Gómez-Reino FJ, Galindo M, Ramos B, et al. Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity 2006;39:205–15.
   PubMed Web of Science ®Google Scholar
• Bronner IM, van der Meulen MFG, de Visser M, Kalmijn S, van Venrooij WJ, Voskuyl AE, et al. Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 2006;65:1456–61.
   PubMed Web of Science ®Google Scholar
• Danieli MG, Gambini S, Pettinari L, Logullo F, Veronesi G, Gabrielli A. Impact of treatment on survival in polymyositis and dermatomyositis. A single-center long-term follow-up study. Autoimmun Rev 2014;13:1048–54.
   PubMed Web of Science ®Google Scholar
• Johnson C, Pinal-Fernandez I, Parikh R, Paik J, Albayda J, Mammen AL, et al. Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease. Lung 2016;194:733–7.
   PubMed Web of Science ®Google Scholar
• Dobloug GC, Garen T, Brunborg C, Gran JT, Molberg Ø. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort. Semin Arthritis Rheum 2015;45:301–8.
   PubMed Web of Science ®Google Scholar
• Lundberg IE, Forbess CJ. Mortality in idiopathic inflammatory myopathies. Clin Exp Rheumatol 2008;26(Suppl 51):S109–14.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang G, Ma L, Zu N. Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol 2012;35:686–91.
   PubMed Web of Science ®Google Scholar
• Zöller B, Li X, Sundquist J, Sundquist K. Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS ONE 2012;7:e33442.
   PubMed Web of Science ®Google Scholar
• Zöller B, Li X, Sundquist J, Sundquist K. Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol 2012;12:41.
   PubMed Web of Science ®Google Scholar
• Lin YN, Lin CL, Chang KC, Kao CH. Increased subsequent risk of acute coronary syndrome for patients with dermatomyositis/polymyositis: a nationwide population-based retrospective cohort study. Scand J Rheumatol 2015;44:42–7.
   PubMed Web of Science ®Google Scholar
• Rai SK, Choi HK, Sayre EC, Aviña-Zubieta JA. Risk of myocardial infarction and ischemic stroke in adults with polymyositis and dermatomyositis: a general population-based study. Rheumatology (Oxford) 2016;55:461–9.
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Suksaranjit P, Spanuchart I, Leeaphorn N, Permpalung N. Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum 2014;44:63–7.
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Cheungpasitporn W, Wijarnpreecha K, Ahuja W, Ratanasrimetha P, Thongprayoon C. Risk of ischemic stroke in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis. Rheumatol Int 2015;35:905–9.
   PubMed Web of Science ®Google Scholar
• Danieli MG, Gelardi C, Guerra F, Cardinaletti P, Pedini V, Gabrielli A. Cardiac involvement in polymyositis and dermatomyositis. Autoimmun Rev 2016;15:462–5.
   PubMed Web of Science ®Google Scholar
• Linos E, Fiorentino D, Lingala B, Krishnan E, Chung L. Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey. Arthritis Res Ther 2013;15:R7.
   PubMed Web of Science ®Google Scholar
• Kim RB, Kim BG, Kim YM, Seo JW, Lim YS, Kim HS, et al. Trends in the incidence of hospitalized acute myocardial infarction and stroke in Korea, 2006-2010. J Korean Med Sci 2013;28:16–24.
   PubMed Web of Science ®Google Scholar
• Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, et al. The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 2018;77:30–9.
   PubMed Web of Science ®Google Scholar
• Lundberg IE, Svensson J. Registries in idiopathic inflammatory myopathies. Curr Opin Rheumatol 2013;25:729–34.
   PubMed Web of Science ®Google Scholar